Sustainability Key To ABL Bio’s Journey From ‘Good To Great’

Goal To Become An R&D-Focused Subsidiary

 
• By Jung Won Shin
  
Sang Hoon Lee, CEO of ABL Bio
Sanofi, GSK Deals Part Of Korean Venture's Goal Of Building Financial Sustainability (ABL Bio)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from South Korea

More from Anticancer